ACADIA Pharmaceuticals (ACAD) Short Interest Ratio & Short Volume → Warren Buffett's 'mystery stock' (From Stansberry Research) (Ad) Free ACAD Stock Alerts $14.93 +0.14 (+0.95%) (As of 01:52 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media ACADIA Pharmaceuticals Short Interest DataCurrent Short Interest12,030,000 sharesPrevious Short Interest11,160,000 sharesChange Vs. Previous Month+7.80%Dollar Volume Sold Short$201.02 millionShort Interest Ratio6.6 Days to CoverLast Record DateApril 30, 2024Outstanding Shares165,220,000 sharesPercentage of Shares Shorted7.28%Today's Trading Volume380,890 sharesAverage Trading Volume1,785,696 sharesToday's Volume Vs. Average21% Short Selling ACADIA Pharmaceuticals ? Sign up to receive the latest short interest report for ACADIA Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartACAD Short Interest Over TimeACAD Days to Cover Over TimeACAD Percentage of Float Shorted Over Time Ad Stansberry ResearchEverybody laughed when he recommended Netflix"This Could be Worth Even More than A.I." Whitney Tilson's nailed many of the most famous stocks of the last 25 years – including Netflix, Amazon, and Apple. Now he's pounding the table on a new technology rolling out across America, which early estimates say could create more wealth than A.I., the personal computer, and the smartphone combined. Click here to see how it could become the No. 1 investment of the next decade. ACADIA Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/202412,030,000 shares $201.02 million +7.8%N/A6.6 $16.71 4/15/202411,160,000 shares $188.49 million -0.4%N/A6.2 $16.89 3/31/202411,200,000 shares $207.09 million +5.4%N/A6.1 $18.49 3/15/202410,630,000 shares $196.44 million -1.7%N/A5.8 $18.48 2/29/202410,810,000 shares $251.22 million +14.8%N/A5.5 $23.24 2/15/20249,420,000 shares $237.20 million +22.7%N/A5.3 $25.18 Get the Latest News and Ratings for ACAD and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ACADIA Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 1/31/20247,680,000 shares $198.99 million -5.3%N/A4.4 $25.91 1/15/20248,110,000 shares $233.00 million +2.5%N/A4.6 $28.73 12/31/20237,910,000 shares $247.66 million +2.9%N/A4.6 $31.31 12/15/20237,690,000 shares $219.78 million -0.5%N/A4 $28.58 11/30/20237,730,000 shares $172.22 million -0.8%N/A4.8 $22.28 11/15/20237,790,000 shares $175.82 million +3.3%N/A5 $22.57 10/31/20237,540,000 shares $170.18 million +4.0%N/A4.7 $22.57 10/15/20237,250,000 shares $167.77 million -19.1%N/A4.4 $23.14 9/30/20238,960,000 shares $186.73 million -16.3%N/A4.8 $20.84 9/15/202310,700,000 shares $264.50 million +5.1%N/A6.6 $24.72 8/31/202310,180,000 shares $275.06 million +4.2%N/A6.5 $27.02 8/15/20239,770,000 shares $280.59 million +10.3%N/A6 $28.72 7/31/20238,860,000 shares $259.07 million +0.9%N/A5.3 $29.24 7/15/20238,780,000 shares $282.54 million +5.0%N/A5.7 $32.18 6/30/20238,360,000 shares $200.22 million -10.9%N/A6.3 $23.95 6/15/20239,380,000 shares $228.78 million -6.6%N/A7 $24.39 5/31/202310,040,000 shares $235.94 million +0.7%N/A6.5 $23.50 5/15/20239,970,000 shares $220.54 million +3.3%N/A6.1 $22.12 4/30/20239,650,000 shares $205.83 million +0.4%6.0%6.1 $21.33 4/15/20239,610,000 shares $172.88 million +17.5%6.0%6 $17.99 3/31/20238,180,000 shares $153.95 million -3.8%5.1%5.2 $18.82 3/15/20238,500,000 shares $168.73 million +5.7%5.3%5.6 $19.85 2/28/20238,040,000 shares $166.35 million -0.3%5.0%6.3 $20.69 2/15/20238,060,000 shares $152.90 million -0.5%5.1%7.1 $18.97 1/31/20238,100,000 shares $154.14 million +1.1%5.1%6.9 $19.03 1/15/20238,010,000 shares $147.38 million -4.5%5.0%6.5 $18.40 12/30/20228,390,000 shares $133.57 million -3.6%5.3%6.8 $15.92 12/15/20228,700,000 shares $131.11 million -10.0%5.5%6.6 $15.07 11/30/20229,670,000 shares $150.66 million +7.0%6.1%7 $15.58 11/15/20229,040,000 shares $141.84 million -13.4%5.7%6.2 $15.69 10/31/202210,440,000 shares $167.35 million +9.7%6.5%6.7 $16.03 10/15/20229,520,000 shares $149.65 million -1.7%6.0%6.1 $15.72 9/30/20229,680,000 shares $158.36 million +0.8%6.1%5.9 $16.36 9/15/20229,600,000 shares $175.39 million -3.7%6.0%5.4 $18.27Warren Buffett's "mystery stock" (Ad)WARNING: Read This Before the Next Fed Meeting Investors are looking to the Fed with high hopes for interest rate relief. Unfortunately, many have no idea there's another major story unfolding right now, one that could be worth $40 trillion. This Wall Street millionaire just stepped forward with all the details, and how it could make some 8/31/20229,970,000 shares $163.81 million -1.5%6.3%3.9 $16.43 8/15/202210,120,000 shares $167.99 million +4.7%6.4%3.9 $16.60 7/31/20229,670,000 shares $142.05 million -0.5%6.8%3.7 $14.69 7/15/20229,720,000 shares $148.52 million -7.0%6.8%3.7 $15.28 6/30/202210,450,000 shares $147.24 million -10.8%7.3%4 $14.09 6/15/202211,720,000 shares $219.98 million -9.1%8.2%4.7 $18.77 5/31/202212,890,000 shares $208.17 million -1.0%8.1%7.7 $16.15 5/15/202213,020,000 shares $219.39 million +8.5%8.2%8 $16.85 4/30/202212,000,000 shares $221.28 million +48.0%7.5%7.6 $18.44 4/15/20228,110,000 shares $190.34 million +17.7%5.1%5.3 $23.47 3/31/20226,890,000 shares $166.88 million -3.1%4.3%4.7 $24.22 3/15/20227,110,000 shares $163.89 million +17.9%4.4%4.4 $23.05 2/28/20226,030,000 shares $153.22 million +1.3%3.8%3.5 $25.41 2/15/20225,950,000 shares $162.32 million +6.6%3.7%3.6 $27.28 1/31/20225,580,000 shares $125.49 million -17.3%3.5%3.3 $22.49 1/15/20226,750,000 shares $155.59 million +2.0%4.2%4.1 $23.05 12/31/20216,620,000 shares $154.51 million +1.9%4.1%4.1 $23.34 12/15/20216,500,000 shares $158.47 million +11.9%4.1%4 $24.38 11/30/20215,810,000 shares $111.55 million -20.6%3.6%4.4 $19.20 11/15/20217,320,000 shares $144.72 million -6.5%4.6%5.9 $19.77 10/29/20217,830,000 shares $140.55 million +3.2%4.9%6.3 $17.95 10/15/20217,590,000 shares $132.90 million +6.8%4.8%5.8 $17.51 9/30/20217,110,000 shares $118.10 million +1.3%4.5%5.5 $16.61 9/15/20217,020,000 shares $111.62 million -3.6%4.4%4.5 $15.90 8/31/20217,280,000 shares $127.47 million -7.7%4.6%4.6 $17.51 8/13/20217,890,000 shares $138.71 million -2.6%4.9%4.8 $17.58 7/30/20218,100,000 shares $175.20 million +0.9%5.1%4.7 $21.63 7/15/20218,030,000 shares $185.97 million -1.7%5.0%4.6 $23.16 6/30/20218,170,000 shares $199.27 million +36.9%5.1%4.3 $24.39 6/15/20215,970,000 shares $156.83 million +2.9%3.7%3 $26.27 5/28/20215,800,000 shares $129.57 million -20.0%3.6%2.6 $22.34 5/14/20217,250,000 shares $153.85 million -3.3%N/A2.7 $21.22 4/30/20217,500,000 shares $154.43 million -6.1%N/A2.9 $20.59 4/15/20217,990,000 shares $170.03 million +14.0%N/A3.3 $21.28 3/31/20217,010,000 shares $180.23 million +7.5%N/A3.1 $25.71 3/15/20216,520,000 shares $176.30 million -1.4%N/A3.6 $27.04 2/26/20216,610,000 shares $312.72 million +7.8%N/A5 $47.31 2/12/20216,130,000 shares $314.10 million +1.0%N/A6.8 $51.24 1/29/20216,070,000 shares $300.71 million -2.6%N/A6.4 $49.54 1/15/20216,230,000 shares $339.29 million -1.6%N/A6.2 $54.46 12/31/20206,330,000 shares $339.86 million -10.0%N/A6.4 $53.69 12/15/20207,030,000 shares $366.47 million -10.3%N/A7 $52.13 11/30/20207,840,000 shares $439.04 million -2.0%N/A7.6 $56.00 11/15/20208,000,000 shares $412.56 million -9.5%N/A7.6 $51.57 10/30/20208,840,000 shares $418.57 million -0.6%N/A7.8 $47.35 10/15/20208,890,000 shares $381.56 million -3.5%N/A7.6 $42.92 9/30/20209,210,000 shares $379.91 million +2.7%N/A6.5 $41.25 9/15/20208,970,000 shares $347.95 million -4.0%N/A4.8 $38.79 8/31/20209,340,000 shares $369.77 million -0.2%N/A5 $39.59 8/14/20209,360,000 shares $368.32 million -5.4%N/A5 $39.35Warren Buffett's "mystery stock" (Ad)WARNING: Read This Before the Next Fed Meeting Investors are looking to the Fed with high hopes for interest rate relief. Unfortunately, many have no idea there's another major story unfolding right now, one that could be worth $40 trillion. This Wall Street millionaire just stepped forward with all the details, and how it could make some 7/31/20209,890,000 shares $411.13 million +4.1%N/A5.6 $41.57 7/15/20209,500,000 shares $523.74 million -3.3%N/A5.5 $55.13 6/30/20209,820,000 shares $475.98 million -14.5%N/A6.3 $48.47 6/15/202011,490,000 shares $534.17 million +2.3%N/A9.2 $46.49 5/29/202011,230,000 shares $557.91 million -2.4%N/A8.7 $49.68 5/15/202011,510,000 shares $585.05 million +0.1%N/A8.4 $50.83 4/30/202011,500,000 shares $555.57 million -5.2%N/A8.4 $48.31 4/15/202012,130,000 shares $548.15 million +5.7%N/A8.9 $45.19 3/31/202011,480,000 shares $584.68 million -5.3%N/A8.1 $50.93 3/13/202012,117,000 shares $530.72 million +3.4%N/A9.7 $43.80 2/28/202011,720,000 shares $410.20 million +2.2%N/A8.2 $35.00 2/14/202011,470,000 shares $470.38 million -0.4%N/A7.7 $41.01 1/31/202011,510,000 shares $462.93 million +2.1%N/A7.6 $40.22 1/15/202011,270,000 shares $494.53 million +1.5%N/A7.3 $43.88 12/31/201911,100,000 shares $436.67 million +7.1%N/A7.1 $39.34 ACAD Short Interest - Frequently Asked Questions What is ACADIA Pharmaceuticals' current short interest? Short interest is the volume of ACADIA Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of April 30th, traders have sold 12,030,000 shares of ACAD short. Learn More on ACADIA Pharmaceuticals' current short interest. What is a good short interest ratio for ACADIA Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ACAD shares currently have a short interest ratio of 7.0. Learn More on ACADIA Pharmaceuticals's short interest ratio. Which institutional investors are shorting ACADIA Pharmaceuticals? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of ACADIA Pharmaceuticals: Walleye Trading LLC, Torno Capital LLC, Twin Tree Management LP, Concourse Financial Group Securities Inc., Simplex Trading LLC, and Goldman Sachs Group Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is ACADIA Pharmaceuticals' short interest increasing or decreasing? ACADIA Pharmaceuticals saw a increase in short interest in April. As of April 30th, there was short interest totaling 12,030,000 shares, an increase of 7.8% from the previous total of 11,160,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does ACADIA Pharmaceuticals' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to ACADIA Pharmaceuticals: Dyne Therapeutics, Inc. (18.91%), Rhythm Pharmaceuticals, Inc. (17.37%), Janux Therapeutics, Inc. (9.55%), Indivior PLC (0.14%), PTC Therapeutics, Inc. (12.95%), MoonLake Immunotherapeutics (14.00%), Bausch Health Companies Inc. (5.73%), Merus (5.76%), Vera Therapeutics, Inc. (16.61%), Maravai LifeSciences Holdings, Inc. (6.66%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short ACADIA Pharmaceuticals stock? Short selling ACAD is an investing strategy that aims to generate trading profit from ACADIA Pharmaceuticals as its price is falling. ACAD shares are trading up $0.14 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against ACADIA Pharmaceuticals? A short squeeze for ACADIA Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ACAD, which in turn drives the price of the stock up even further. How often is ACADIA Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ACAD, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: Dyne Therapeutics Short Interest Rhythm Pharmaceuticals Short Interest Janux Therapeutics Short Interest Indivior Short Interest PTC Therapeutics Short Interest MoonLake Immunotherapeutics Short Interest Bausch Health Companies Short Interest Merus Short Interest Vera Therapeutics Short Interest Maravai LifeSciences Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ACAD) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldDoes this make you sick?Allegiance GoldDems have chosen Biden replacement?Paradigm PressThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaThis Apple-like Innovator is Revolutionizing HealthcareWall Street Star**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! Huge AlertsThis Could be Your “Big Money” AI MomentInvestorPlaceDigitizing the $11T commodities sector with one tiny stockResource Stock Digest